RARE
Ultragenyx Pharmaceutical Inc.
$17.73+1.03 (+6.17%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jan 31, 2014 – Nov 18, 2026, Dividends reinvested
- Final balance
- $4,196
- CAGR
- −6.56%
- Max drawdown
- −92.74%
Trailing returns (%)
RARE's average annual return was −14.27% over the last 10 years, through Nov 18, 2026. $10,000 in RARE on Nov 18, 2016 fell to $2,143 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +21.94%
- 3M
- −30.44%
- 6M
- −26.71%
- YTD
- −22.91%
- 1Y
- −45.99%
Per year
- 3Y
- −23.74%
- 5Y
- −25.53%
- 10Y
- −14.27%
- Since 2014
- −6.56%
Annual returns
2014 from Jan 31 · 2026 through Nov 18
RARE returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −22.91% |
| 2025 | −45.33% |
| 2024 | −12.02% |
| 2023 | +3.22% |
| 2022 | −44.90% |
| 2021 | −39.25% |
| 2020 | +224.12% |
| 2019 | −1.77% |
| 2018 | −6.25% |
| 2017 | −34.03% |
| 2016 | −37.32% |
| 2015 | +155.65% |
| 2014 from Jan 31 | +3.86% |
Metrics
Since 2014| Volatility | 59.51% |
|---|---|
| Sharpe ratio | 0.19 |
| Sortino ratio | 0.27 |
| Calmar ratio | −0.07 |
| Longest drawdown | 5.9 years |
Worst drawdowns
Since 2014| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −92.7% | Dec 2020 | Sep 2026 | Not yet | 5.9 years so far |
| −74.8% | Jul 2015 | Mar 2020 | Dec 2020 | 5.4 years |
| −49.6% | Mar 2014 | May 2014 | Apr 2015 | 1.1 years |
| −19.0% | Apr 2015 | Apr 2015 | May 2015 | 3 weeks |
| −14.6% | Jan 2014 | Feb 2014 | Feb 2014 | 2 weeks |